DrugId:  1
1. Name:  BCG vaccine
2. Groups:  Investigational
3. Description:  BCG vaccine has been investigated for the treatment of Neoplasms, Bladder Cancer, Neoplasms by Site, Urologic Diseases, and Urologic Neoplasms, among others.
4. Indication:  Not Available
DrugId:  2
1. Name:  Enfortumab vedotin
2. Groups:  Investigational
3. Description:  Enfortumab vedotin has been used in trials studying the treatment of Tumors, Neoplasms, and Medical Oncology.
4. Indication:  Not Available
DrugId:  3
1. Name:  Patritumab
2. Groups:  Investigational
3. Description:  Patritumab has been used in trials studying the treatment of LUNG CANCER, Solid Tumors, Neoplasms by Site, Head and Neck Neoplasms, and Non-small Cell Lung Cancer, among others.
4. Indication:  Not Available
DrugId:  4
1. Name:  Figitumumab
2. Groups:  Investigational
3. Description:  Figitumumab has been used in trials studying the treatment of Sarcoma, Solid Tumor, Breast Cancer, Lung Neoplasms, and Advanced Cancer, among others.
4. Indication:  Not Available
DrugId:  5
1. Name:  Ganitumab
2. Groups:  Investigational
3. Description:  Ganitumab has been used in trials studying the treatment of Colon Cancer, Rectal Cancer, Breast Cancer, Breast Tumors, and Breast Neoplasms, among others.
4. Indication:  Not Available
DrugId:  6
1. Name:  Amatuximab
2. Groups:  Investigational
3. Description:  Amatuximab has been used in trials studying the treatment and basic science of Mesothelioma, Ovarian Cancer, Ovarian Neoplasms, Pancreatic Cancer, and Mesothelioma, Malignant, among others.
4. Indication:  Not Available
DrugId:  7
1. Name:  Lumretuzumab
2. Groups:  Investigational
3. Description:  Lumretuzumab has been used in trials studying the treatment of Neoplasms, Breast Cancer, Squamous Non-Small Cell Lung Cancer, and Non-Squamous Non-Small Cell Lung Cancer.
4. Indication:  Not Available
DrugId:  8
1. Name:  5-fluoro-2'-deoxycytidine
2. Groups:  Investigational
3. Description:  5-fluoro-2'-deoxycytidine has been used in trials studying the treatment of Neoplasms, Lung Neoplasms, Breast Neoplasms, Head and Neck Neoplasms, and Urinary Bladder Neoplasms, among others.
4. Indication:  Not Available
DrugId:  9
1. Name:  Terconazole
2. Groups:  Approved
3. Description:  Terconazole is an anti-fungal medication, primarily used to treat vaginal fungal infections. [Wikipedia]
4. Indication:  For the treatment of candidiasis (a yeast-like fungal infection) of the vulva and vagina.
DrugId:  10
1. Name:  Nonoxynol-9
2. Groups:  Approved, Withdrawn
3. Description:  Nonoxynol-9 (N-9) is a typical surfactant used as a vaginal spermicide. Spermicides are locally acting non-hormonal contraceptives. When present in the vagina during intercourse, they immobilize/inactivate/damage and/or kill sperms without eliciting systemic effects. N-9 has been in use for more than 30 years as an over-the-counter (OTC) drug in creams, gels, foams and condom lubricants. It is the most commonly used spermicidal contraceptive in the UK and the USA. In several European countries, spermicides are no longer on the market.
4. Indication:  Nonoxynol 9 is a surfactant spermicide used for contraception in spermicidal creams, jellies, foams, gel, and lubricants. It is also used in conjuction with other methods of contraception, including condoms, cervical caps and diaphragms.
DrugId:  11
1. Name:  APR-246
2. Groups:  Investigational
3. Description:  APR-246 has been used in trials studying the treatment of Prostatic Neoplasms, Hematologic Neoplasms, and Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53.
4. Indication:  Not Available
DrugId:  12
1. Name:  Butoconazole
2. Groups:  Approved
3. Description:  Butoconazole is an imidazole antifungal used in gynecology.
4. Indication:  For the local treatment of vulvovaginal candidiasis (infections caused by Candida)
DrugId:  13
1. Name:  Miconazole
2. Groups:  Approved, Investigational, Vet approved
3. Description:  An imidazole antifungal agent that is used topically and by intravenous infusion. [PubChem]
4. Indication:  For topical application in the treatment of tinea pedis (athleteâ€™s foot), tinea cruris, and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, in the treatment of cutaneous candidiasis (moniliasis), and in the treatment of tinea versicolor.
DrugId:  14
1. Name:  Tetrahydrouridine
2. Groups:  Investigational
3. Description:  Tetrahydrouridine has been used in trials studying the treatment of Neoplasms, Lung Neoplasms, Breast Neoplasms, Sickle Cell Disease, and Head and Neck Cancer, among others.
4. Indication:  Not Available
DrugId:  15
1. Name:  Onartuzumab
2. Groups:  Investigational
3. Description:  Onartuzumab has been used in trials studying the treatment of Neoplasms, Lung Cancer, Glioblastoma, Gastric Cancer, and Colorectal Cancer, among others.
4. Indication:  Not Available
DrugId:  16
1. Name:  Duligotuzumab
2. Groups:  Investigational
3. Description:  Duligotuzumab has been used in trials studying the treatment of Neoplasms, Colorectal Cancer, Head and Neck Cancer, and Epithelial Tumors, Malignant.
4. Indication:  Not Available
DrugId:  17
1. Name:  Ascrinvacumab
2. Groups:  Investigational
3. Description:  Ascrinvacumab has been used in trials studying the treatment and basic science of Neoplasms, Advanced Solid Tumors, Carcinoma, Hepatocellular, and Malignant Pleural Mesothelioma.
4. Indication:  Not Available
DrugId:  18
1. Name:  Atamestane
2. Groups:  Investigational
3. Description:  Atamestane has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasms, Hormone-Dependent.
4. Indication:  Not Available
DrugId:  19
1. Name:  Clotrimazole
2. Groups:  Approved, Vet approved
3. Description:  An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal cell membranes. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane. [PubChem]
4. Indication:  For the local treatment of oropharyngeal candidiasis and vaginal yeast infections, also used in fungal infections of the skin such as ringworm, athlete's foot, and jock itch.
DrugId:  20
1. Name:  ZD-6126
2. Groups:  Investigational
3. Description:  ZD6126 has been used in trials studying the treatment of Kidney Neoplasms, Colorectal Neoplasms, Metastases, Neoplasm, and Carcinoma, Renal Cell.
4. Indication:  Not Available
DrugId:  21
1. Name:  Mitometh
2. Groups:  Investigational
3. Description:  Mitometh is under investigation for the treatment of Adenocarcinoma, Oropharyngeal Neoplasms, Nasopharyngeal Carcinoma, Non-small Cell Lung Cancer, and Stage IV Non-small Cell Lung Cancer, among others. Mitometh has been investigated for the treatment of Lung Neoplasms, Untreated Childhood Medulloblastoma, and Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor.
4. Indication:  Not Available
DrugId:  22
1. Name:  CP-547632
2. Groups:  Investigational
3. Description:  CP-547632 has been used in trials studying the treatment of Ovarian Cancer, Lung Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms, and Fallopian Tube Cancer, among others.
4. Indication:  Not Available
DrugId:  23
1. Name:  C31G
2. Groups:  Investigational
3. Description:  C31G is a potent broad spectrum antimicrobial agent, effective against gram positive and gram negative bacteria, yeast and fungi.C31G, vaginal gel is developed by Biosyn Inc. and has commenced enrollment in a phase III pivotal clinical trial for the reduction of sexual transmission of human immunodeficiency virus (HIV).
4. Indication:  Investigated for use/treatment in contraception, HIV infection, and prevention of stdis.
DrugId:  24
1. Name:  Lapachone
2. Groups:  Investigational
3. Description:  Lapachone has been used in trials studying the treatment of Cancer, Carcinoma, Advanced Solid Tumors, Head and Neck Neoplasms, and Carcinoma, Squamous Cell.
4. Indication:  Not Available
DrugId:  25
1. Name:  MK-1496
2. Groups:  Investigational
3. Description:  MK-1496 has been used in trials studying the treatment of Neoplasms and Malignant.
4. Indication:  Not Available
